Position in AMGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$34,987,310
+$1,180,860 QoQ
Shares Held
96,618
+0.6% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#267
of 3,140 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ZACKS INVESTMENT MANAGEMENT holds $890,953,075 across 8 Drug Manufacturers - General names. AMGN ranks #7 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
875,123 | $222,254,988 | |
| 2 | ABBV |
AbbVie Inc.
|
815,433 | $205,195,560 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,087,644 | $139,762,254 | |
| 4 | LLY |
ELI LILLY & Co
|
114,449 | $137,273,575 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
530,870 | $67,070,115 | |
| 6 | PFE |
Pfizer Inc
|
2,658,388 | $64,013,983 | |
| 7 | AMGN |
Amgen Inc
This page
|
96,618 | $34,987,310 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
353,962 | $20,395,290 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,987,310 | 96,618 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $33,806,450 | 96,082 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $31,203,771 | 95,334 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $26,309,788 | 93,231 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $26,036,332 | 93,250 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $29,451,756 | 94,533 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $23,820,410 | 91,392 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $31,776,027 | 98,619 | Shares | Sole | 2024-11-14 | |
| 2024-03-31 | $24,007,412 | 84,438 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $22,941,945 | 79,654 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $21,277,191 | 79,168 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $17,371,066 | 78,241 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $18,679,055 | 77,266 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $24,574,699 | 93,568 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $20,266,390 | 89,913 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $21,565,868 | 88,639 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $16,572,408 | 68,532 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $14,739,359 | 65,517 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $13,698,275 | 64,417 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $15,624,862 | 64,102 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $16,158,965 | 64,945 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $51,949,274 | 225,945 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $61,989,624 | 243,900 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $61,916,316 | 262,513 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $52,685,066 | 259,878 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||